FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas
CBER links
horizontal rule

Product Approval Information - Licensing Action

horizontal rule

Proper name: Haemophilus b Conjugate (Meningococcal Protein Conjugate) and Hepatitis B (Recombinant)
Tradename: COMVAX
Manufacturer: Merck & Co, Inc, West Point, PA, License #0002
Indication for Use: Immunization of persons 6 weeks to 15 months of age born to hepatitis B surface antigen (HBsAg) negative mothers
Approval Date: 10/2/96
Type of submission: Product license application

horizontal rule

Approval Letter - (PDF), (Text)

Label - (PDF)

 

Updated March 5, 2001
 
horizontal rule

CBER Home Page | CBER A-Z Index | CBER Search | Contact CBER
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page

FDA / Center for Biologics Evaluation and Research